Related Experiment Videos
[Myocarditis. Epidemiology, etiology and clinical aspects]
1Infektionskliniken, Akademiska sjukhuset, Uppsala.
Nordisk Medicin
|January 1, 1994
Summary
Myocarditis is a diverse condition, often caused by enteroviruses like Coxsackie B. While diagnosis relies on ECG and biomarkers, treatment for viral myocarditis remains limited, with immunosuppression ineffective for biopsy-confirmed cases.
Area of Science:
- Cardiology
- Pathology
- Virology
Context:
- Myocarditis encompasses various pathological conditions, with acute infective myocarditis, often enterovirus-induced, being well-documented.
- Advances in understanding viral myocarditis pathogenesis reveal mechanisms of myocardial damage.
- Coxsackie viruses are implicated in dilated cardiomyopathy development.
Purpose:
- To review the etiological diversity, diagnostic approaches, and therapeutic limitations of myocarditis.
- To highlight the role of enteroviruses, particularly Coxsackie B, in myocarditis and dilated cardiomyopathy.
- To discuss the diagnostic criteria and prognostic factors associated with different forms of myocarditis.
Summary:
- Acute infective myocarditis, predominantly caused by enteroviruses (e.g., Coxsackie B), is the most documented form.
- Diagnosis often relies on electrocardiogram (ECG) findings and serum biochemical markers, supported by echocardiography.
- Current treatments, including antiviral agents and immunosuppression (for biopsy-confirmed cases), have limited efficacy.
Impact:
- Provides a comprehensive overview of myocarditis, aiding clinicians in diagnosis and management.
- Emphasizes the etiological link between viral infections and myocardial disease, including dilated cardiomyopathy.
- Underscores the need for further research into effective therapeutic strategies for viral myocarditis.